Two large trials, DREAM and MENSA have found IL-5 therapy with mepolizumab to lower risk of exacerbation in patients with asthma with an eosinophilic phenotype.
Asthma exacerbations are linked to variations in air allergens, respiratory infections, and weather. A study evaluated 2,637 young adult asthma patients. Skin prick test was used to identify sensitizations and asthma attacks were assessed by questionnaire. Patients report more frequent asthma attacks during certain times of the year, ranging from 47% in Sweden to 87% in Spain. These variations were unrelated to sensitization to house dust mite or cat.
Southern European patients with grass sensitization were more likely to report asthma attacks in spring or summer versus winter: odds ratio (OR) 2.60 in March/April versus 4.43 in May/June. In contrast, for Northern European patients, the peaks were smaller and appeared later in the year: OR 1.25 in May/June and 1.66 in July/August. Asthma patients with self-reported hay fever but without grass sensitization did not have seasonal variations.
You Might Also Enjoy...
Two large trials, DREAM and MENSA have found IL-5 therapy with mepolizumab to lower risk of exacerbation in patients with asthma with an eosinophilic phenotype.
Mold allergy is difficult to diagnose due to lack of standardized test material.
The current standard for diagnosis of Eosinophilic Esophagitis (EoE) is endoscopy with esophageal biopsy to determine the eosinophil count
Skin prick testing and serum IgE measurement are limited in their ability to predict positive or negative responses to oral peanut challenge.
Bronchial Thermoplasty (BT) has been shown to result in significant improvements in a number of asthma control measures in three randomized clinical trials in patients with moderate-to-severe, persistent asthma.
Recent studies have suggested that early regular exposure to allergenic foods may reduce the risk of food allergy.